Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study

被引：0
|
作者：
Li Ying
Ji Suyun
Liang Yanhua
Liang Yunsheng
Deng Li
Dang Lin
Lv Chengzhi
Lin Bingjiang
Zhang Furen
Shi Wendi
Li Jinnan
Dong Yu
Dou Guanshen
Yuling Shi
机构：
[1] Tongji University School of Medicine,Department of Dermatology, Shanghai Skin Disease Hospital
[2] Southern Medical University,Department of Dermatology, Dermatology Hospital
[3] Southern Medical University,Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital
[4] Longgang Central Hospital of Shenzhen,Department of Dermatology
[5] Dalian Skin Disease Hospital,Department of Dermatology
[6] Ningbo First Hospital,Department of Dermatology
[7] Shandong First Medical University & Shandong Academy of Medical Sciences,Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology
[8] Eli Lilly and Company,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Efficacy; Ixekizumab; Psoriasis; Real world; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5464 / 5474
页数：10
相关论文
共 50 条
  • [21] Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
    Ying Li
    Chengzhi Lv
    Lin Dang
    Bingjiang Lin
    Juan Tao
    Chunlei Zhang
    Xiaoyong Zhou
    Han Ma
    Yi Lu
    Rong Chen
    Jinnan Li
    Guanshen Dou
    Yunsheng Liang
    Yanhua Liang
    Yuling Shi
    Dermatology and Therapy, 2024, 14 : 907 - 918
  • [22] Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
    Huang He
    Chen Min
    Wu Wenjuan
    Yang Tianhui
    Liu Hao
    Zhu Zhengwei
    Wang Wenjun
    Yang Sen
    Ding Xian
    Wang Hui
    Sheng Yujun
    Zhang Yaohua
    Li Min
    Zhang Xuejun
    中华医学杂志英文版, 2023, 136 (03)
  • [23] Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis: a real-life cohort study
    Zhao, Yan
    Cai, Lin
    Liu, Xiao-Yang
    Zhang, Heng
    Zhang, Jian-Zhong
    CHINESE MEDICAL JOURNAL, 2021, 134 (11) : 1324 - 1328
  • [24] Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
    Huang, He
    Chen, Min
    Wu, Wenjuan
    Yang, Tianhui
    Liu, Hao
    Zhu, Zhengwei
    Wang, Wenjun
    Yang, Sen
    Ding, Xian
    Wang, Hui
    Sheng, Yujun
    Zhang, Yaohua
    Li, Min
    Zhang, Xuejun
    CHINESE MEDICAL JOURNAL, 2023, 136 (03) : 360 - 361
  • [25] Comment on "Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis"
    Lebwohl, Mark G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E377 - E377
  • [26] Safety and tolerability of ixekizumab: analysis of neutropenia in 7 clinical studies of moderate-to-severe plaque psoriasis
    Strober, B.
    Pangallo, B. A.
    Veenhuizen, M. F.
    Xu, W.
    Russell, J. M.
    Blauvelt, A.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E10 - E10
  • [27] Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis
    Saeki, H.
    Nakagawa, H.
    Ishii, T.
    Morisaki, Y.
    Aoki, T.
    Berclaz, P. -Y.
    Heffernan, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (06) : 1148 - 1155
  • [28] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis Reply
    Gordon, Kenneth B.
    Colombel, Jean-Frederic
    Hardin, Dana S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2102 - 2102
  • [29] Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
    Egeberg, A.
    Ottosen, M. B.
    Gniadecki, R.
    Broesby-Olsen, S.
    Dam, T. N.
    Bryld, L. E.
    Rasmussen, M. K.
    Skov, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 509 - 519
  • [30] Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
    Egeberg, A.
    Ottosen, M. B.
    Gniadecki, R.
    Broesby-Olsen, S.
    Dam, T.
    Bryld, L. E.
    Rasmussen, M. K.
    Skov, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E284 - E285
12345